Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
33.36
+0.41 (1.24%)
Jan 22, 2026, 1:26 PM EST - Market open
Genmab Market Cap
Genmab has a market cap or net worth of $20.51 billion as of January 22, 2026. Its market cap has increased by 47.59% in one year.
Market Cap
20.51B
Enterprise Value
17.24B
1-Year Change
47.59%
Ranking
Category
Stock Price
$33.36
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $20.51B, an increase of 4,777.85%. That is a compound annual growth rate of 32.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 20.12B | 1.72% |
| Dec 31, 2025 | 19.78B | 43.19% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
| Apr 23, 2012 | 420.50M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Insmed | 33.34B |
| BioNTech SE | 29.61B |
| Royalty Pharma | 22.93B |
| Revolution Medicines | 22.72B |
| Incyte | 20.55B |
| Moderna | 19.46B |
| Roivant Sciences | 15.98B |
| BridgeBio Pharma | 15.06B |